De novo pauci-immune glomerulonephritis in renal allografts. 2020

Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. buglioni.alessia@mayo.edu.

Pauci-immune glomerulonephritis in the native kidney presents with renal insufficiency, proteinuria, and hematuria, and is usually due to anti-neutrophil cytoplasmic antibodies. Rarely, kidney transplants can show this pattern as de novo disease. We performed a retrospective analysis in 10 cases of de novo pauci-immune glomerulonephritis. The mean time from transplant to diagnostic biopsy was 32 months (range, 4-96). All biopsies showed focal necrotizing or crescentic glomerulonephritis (mean 16% glomeruli, range 2-36%). Immunofluorescence and electron microscopy showed a pauci-immune pattern. No patients had evidence of systemic vasculitis. Anti-neutrophil cytoplasmic antibody results were available for 7 patients and were negative in all but one. Most patients had functioning grafts at one year after diagnosis. Two patients had repeat biopsies that showed continued active glomerulonephritis. We report the first clinicopathologic series of de novo pauci-immune glomerulonephritis which appears to be a unique pathologic entity that may occur early or late post-transplant and in our cohort is not associated with systemic vasculitis and usually not associated with anti-neutrophil cytoplasmic antibodies. The degree of crescent formation and renal impairment are milder than those of pauci-immune crescentic glomerulonephritis in the native kidney.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
July 1988, Clinical nephrology,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
May 1989, Clinical nephrology,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
March 2006, Transplantation proceedings,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
August 2008, Nature clinical practice. Nephrology,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
December 2002, Transplantation proceedings,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
January 2017, Clinical and experimental rheumatology,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
October 2023, Journal of Korean medical science,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
May 2017, Internal medicine journal,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
January 2021, Indian journal of nephrology,
Alessia Buglioni, and Mary E Fidler, and Mariam P Alexander, and Sanjeev Sethi, and Samih H Nasr, and Loren P Herrera Hernandez, and Joseph P Grande, and Fernando G Cosio, and Lynn D Cornell
August 2010, Rheumatic diseases clinics of North America,
Copied contents to your clipboard!